(Bloomberg) -- In a year that has seen high-flying technology stocks with lofty valuations battered, Tesla Inc. shares have emerged as an unlikely rival to Apple Inc.Most Read from BloombergJohn Paulson on Frothy US Housing Market: This Time Is DifferentUK Market Selloff Slams Gilts, Pound, Piling Pressure on BOEWall Street Banks Prep for Grim China Scenarios Over TaiwanBank of England Says Paper Banknotes Only Good for One More WeekInterpol Issues Red Notice for Terra’s Do Kwon, Korea SaysOf th
Dan Loeb has changed his tune on ESPN. In August, the activist investor wrote a letter urging Walt Disney (NYSE: DIS) CEO Bob Chapek to spin off the sports media company. But after Chapek presented at Disney's annual D23 conference and talked to reporters about ESPN and the future of Disney, Loeb's now convinced ESPN is worth more within Disney.
Let's examine two stocks worth keeping in this challenging market and beyond: Abbott Laboratories (NYSE: ABT) and Apple (NASDAQ: AAPL). Abbott Laboratories focuses on medical devices, although it has a diversified business with multiple segments that allow it to navigate difficult times. For instance, when the company's medical devices segment took a hit during the pandemic, its diagnostics unit picked up the slack.